Prelude Therapeutics Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2024 | 10.91 M | $22.58 M | 0.00% | 14.38% |
| BAKER BROS. ADVISORS LP | 11/14/2024 | 10.12 M | $20.96 M | 0.00% | 13.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 3.77 M | $7.80 M | -8.88% | 4.96% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.71 M | $3.54 M | -33.49% | 2.25% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.10 M | $2.27 M | 23.15% | 1.45% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.06 M | $2.19 M | 100.00% | 1.40% |
| VANGUARD GROUP INC | 11/13/2024 | 1.02 M | $2.12 M | 1.11% | 1.35% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 921,621 | $1.91 M | 100.00% | 1.22% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2024 | 890,000 | $1.84 M | 100.00% | 1.17% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 549,530 | $1.14 M | 5.20% | 0.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 391,716 | $810,941 | 8.22% | 0.52% |
| MARSHALL WACE, LLP | 11/14/2024 | 359,137 | $743,414 | 100.00% | 0.47% |
| MORGAN STANLEY | 11/14/2024 | 323,689 | $670,036 | 12.64% | 0.43% |
| STATE STREET CORP | 11/14/2024 | 286,046 | $592,115 | 35.09% | 0.38% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 281,583 | $583,000 | 100.00% | 0.37% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 196,900 | $407,583 | -4.70% | 0.26% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 176,100 | $364,527 | 42.48% | 0.23% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 174,979 | $362,207 | 885.19% | 0.23% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 160,652 | $340,582 | 0.00% | 0.21% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 160,524 | $332,285 | 100.00% | 0.21% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 133,249 | $275,825 | 4.07% | 0.18% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 95,161 | $196,983 | 27.01% | 0.13% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 83,175 | $172,172 | 446.16% | 0.11% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 74,143 | $152,000 | 235.34% | 0.10% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 70,045 | $144,993 | 0.00% | 0.09% |
| EXCHANGE TRADED CONCEPTS, LLC | 10/10/2024 | 64,409 | $133,327 | 32.18% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 56,933 | $117,851 | 31.99% | 0.08% |
| XTX TOPCO LTD | 11/14/2024 | 48,239 | $99,855 | 100.00% | 0.06% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 47,900 | $99,153 | -5.89% | 0.06% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 40,102 | $83,010 | 100.00% | 0.05% |
| CERITY PARTNERS LLC | 11/12/2024 | 32,875 | $68,051 | 100.00% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 29,082 | $60,269 | 0.03% | 0.04% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 28,613 | $59,229 | -21.12% | 0.04% |
| BARCLAYS PLC | 11/19/2024 | 27,165 | $57,000 | 86.05% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 24,944 | $51,634 | -27.23% | 0.03% |
| SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 20,048 | $41,499 | 100.00% | 0.03% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 17,293 | $35,797 | 40.08% | 0.02% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 16,797 | $34,770 | 0.00% | 0.02% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 15,534 | $32,155 | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 15,225 | $31,516 | -51.49% | 0.02% |
| RHUMBLINE ADVISERS | 11/12/2024 | 12,004 | $24,840 | -44.34% | 0.02% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 11,295 | $23,381 | 100.00% | 0.01% |
| JANE STREET GROUP, LLC | 11/15/2024 | 10,361 | $21,447 | -19.98% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 9,332 | $19,000 | 100.00% | 0.01% |
| FMR LLC | 11/13/2024 | 7,618 | $15,769 | -20.44% | 0.01% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 7,271 | $15,051 | -10.62% | 0.01% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 7,049 | $14,591 | -0.61% | 0.01% |
| UBS GROUP AG | 11/14/2024 | 7,016 | $14,523 | -35.83% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 6,053 | $12,530 | 4.51% | 0.01% |
| JPMORGAN CHASE & CO | 12/26/2024 | 5,966 | $12,350 | 1.81% | 0.01% |
Prelude Therapeutics Incorporatedinstitutional Ownership - FAQ's
During the previous two years, 76 institutional investors and hedge funds held shares of Prelude Therapeutics Incorporated. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 10.91 M
BAKER BROS. ADVISORS LP: 10.12 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.77 M
Boxer Capital, LLC: 1.71 M
PRICE T ROWE ASSOCIATES INC /MD/: 1.1 M
BlackRock Funding, Inc. /DE: 1.06 M
47.14% of Prelude Therapeutics Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 36.73 M shares in the last 24 months. This purchase volume represents approximately $51.43 M in transactions.